March 16, 2021 Geriatrics NACI to recommend AZ vaccine for Canadians over age 65 based on positive real-world results after millions of doses. It has a comparable reduction in the risk of symptomatic disease and hospitalization compared to 18-64 year-olds.
March 12, 2021 Epidemiology Does Oxford-AstraZeneca vaccine increase risk of blood clots? To conclude this would require evidence that incidence exceeds what is normally expected in the general population. To date, this is not the case according to reports from health authorities.
February 28, 2021 Sunday House Call Shows Vaccine choice? They all work. They all prevent what matters most: severe disease and hospitalization. No need to wait for one over the other.
February 4, 2021 Allergy/Immunology Lancet posts Oxford Vaccine Group preprint study on how the timing of the booster dose of its Oxford-AZ vaccine affects the immune response and efficacy for people 18-55 years of age.